We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue
Sekisui Diagnostics

Download Mobile App




In Other News

Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic has signed a definitive agreement to acquire precision oncology company Reveal Genomics. Read more
20 Oct 2026 | Industry
Image: The study analyzed saliva samples from people undergoing treatment for OCD (Image Credit: Adobe Stock)

Study Links Saliva-Based Epigenetic Signals to OCD Treatment Outcomes

New findings link DNA methylation markers to OCD psychotherapy response, supporting personalized treatment. Read more
20 Oct 2026 | Clinical Chem.
Image: The newly released RepX uses Electronic Genome Mapping (EGM) data generated on the OhmX Platform (Photo courtesy of Nabsys)

Genomic Tool Supports Analysis of Repeat Expansions Linked to Inherited Disorders

A newly launched analysis pipeline now uses electronic genome mapping data to investigate disease-associated repeat expansions Read more
20 Oct 2026 | BioResearch
Image: The definitive agreement covers Myriad Genetics’ Prenatal Health testing business, including the Prequel, Foresight, SneakPeek, and FirstGene tests. (Photo courtesy of Myriad Genetics)

Myriad Genetics to Sell Prenatal Testing Portfolio to Labcorp

Myriad Genetics has entered into a definitive agreement to sell its Prenatal Health testing business to Labcorp for $210 million. Read more
20 Oct 2026 | Industry
Image Credit: iStock

Managed Care Report Examines Barriers to Breast Cancer Biomarker Testing

A new analysis examines uncertainty around biomarker testing and managed care for advanced breast cancer with ESR1 mutations. Read more
20 Oct 2026 | Industry
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

A new collaboration aims to develop bone marrow immune profiling tests to measure disease burden before and after treatment. Read more
20 Oct 2026 | Immunology
Image Credit: iStock

Clinical Trial Evaluates Liquid Biopsy for Early-Stage Breast Cancer Detection

A new blood test analyzes rare cells and vesicles to complement mammography and detect Stage I breast cancer. Read more
20 Oct 2026 | Molecular Diagnostics
Image: Cell culture of induced pluripotent stem cells (iPSCs). Neurons are shown in green and astrocytes in red. (Photo courtesy of Carlos Avilés Granados)

CSF Biomarker Meprin-Beta Increases in Alzheimer’s Disease

New findings show elevated active meprin-β in brain and CSF in Alzheimer’s disease, suggesting utility as a biomarker. Read more
20 Oct 2026 | BioResearch
Image: Latest trends show that cancer diagnosis is evolving beyond a process focused mainly on medical imaging and microscopic tissue examination toward a more layered approach that incorporates molecular and genomic testing, liquid biopsy, digital pathology, and AI (Image Credit: iStock)

Expanding Screening and Biomarker Testing Drive Cancer Diagnostics Market Growth

New data forecast the cancer diagnostics market to reach USD 41.5B by 2031 at 7.2% CAGR amid growth in IVDs and liquid biopsy Read more
20 Oct 2026 | Industry
Image Credit: 123RF

Molecular Panel Gains WHO Emergency Use Listing to Support Ebola Outbreak Response

WHO grants Emergency Use Listing to a molecular panel for testing Ebola and other high-risk pathogens from whole blood. Read more
20 Oct 2026 | Microbiology
Image: The MyChoice CDx test, currently used as a companion diagnostic in ovarian cancer, will generate the PrGIS score and is being advanced for use in prostate cancer. (Photo courtesy of Myriad Genetics)

Collaboration Advances Genomic Instability Biomarker for Prostate Cancer

A new collaboration aims to advance a prostate cancer genomic instability score for clinical trials and companion diagnostics. Read more
20 Oct 2026 | Industry
IMage: Labcorp will acquire BioReference Health’s 4Kscore Test, an FDA-approved blood test that helps predict the likelihood of aggressive prostate cancer before biopsy. (Photo courtesy of OPKO Health

Labcorp Acquisition to Strengthen Specialty Testing and Prostate Cancer Assessment

Labcorp has entered into an agreement with OPKO Health to acquire select assets of BioReference Health. Read more
20 Oct 2026 | Industry
Image: NeoGenomics selected Indica Labs’ HALO AP platform to eable its digital pathology operations through a scalable, cloud-based framework (Photo courtesy of Indica Labs)

Expanded Partnership Scales AI-Powered Digital Pathology for Oncology

NeoGenomics has expanded its partnership with Indica Labs to scale AI-powered digital pathology across its enterprise. Read more
20 Oct 2026 | Industry

Channels

Clinical Chemistry

view channel
Multimodal Clinical Data Models Predict Cachexia Risk Across Cancers
Study Evaluates Alzheimer’s Blood Biomarker Across Racial and Ethnic Groups
Blood Protein May Help Identify Treatment-Resistant Psychosis
Image: A new pilot rapid test for syphilis from a team led by Penn State researchers integrates two blood tests into one and detects bacteria at very low levels to detect the disease in its earliest stages. (Photo courtesy of Pan Research Lab / Penn State)

New One-Step Syphilis Test Could Enable Earlier Detection and Faster Treatment

Syphilis can be difficult to diagnose because its symptoms may resemble other diseases and appear and disappear without treatment. Undetected infection can continue causing harm, spread to partners and... Read more

Molecular Diagnostics

view channel
Modeling Study Shows Blood-Based CRC Screening Could Prevent More Deaths Than Stool...
AI Tool Classifies Pathogenic Variants in Severe Childhood Epilepsy
Noninvasive Cervical Test Detects Endometrial Cancer for Triage
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Hematology

view channel
Handheld Point-of-Care Test Aims to Enable Rapid Coagulation Assessment in Traum...
New Donor Genetic Marker May Help Predict Stem Cell Transplant Success
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Image: The recommendations include extended molecular testing at diagnosis to identify high-risk mutations and guide care. (Image Credit: Adobe Stock)

New Myelofibrosis Guidelines Recommend Expanded Genetic Testing at Diagnosis

Myelofibrosis is a rare, life-threatening blood cancer affecting up to six per 100,000 people. The disease causes scarring in the bone marrow, limiting the production of healthy blood cells and potentially... Read more

Immunology

view channel
Longitudinal Blood Testing Reveals Changes in Allergen Sensitization During Chil...
FDA Approval Adds Automated Testing Option for Parvovirus B19 Serology
Blood-Based Immune Aging Map Could Help Spot Disease Risk Earlier
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Microbiology

view channel
Oral and Lung Microbiome Changes Linked to Severe Long Covid Symptoms
Study Finds Distinct Malaria Parasites Linked to Sickle Cell Trait Protection
Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis
Image: The TriVerity Test System includes a disposable TriVerity cartridge and the Myrna instrument. It measures 29 host mRNAs from blood and uses machine learning to provide bacterial, viral, and illness severity scores in about 30 minutes. (Photo courtesy of Inflammatix)

Rapid Host-Response Test Aims to Predict Corticosteroid Benefit in Sepsis

Sepsis and severe infections are difficult to treat because patients with similar clinical presentations may have very different underlying immune responses. Corticosteroids are commonly used in severe... Read more

Pathology

view channel
Updated Digital Pathology Platform Expands AI Integration for Cancer Diagnosis
AI Histopathology Tool Distinguishes Ewing Sarcoma for Diagnosis
Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions
Image: TissueCypher analyzes protein biomarkers and tissue architecture in biopsy samples to estimate five-year risk of progression to high-grade dysplasia or esophageal adenocarcinoma. (Photo courtesy of Castle Biosciences)

Molecular Testing Refines Barrett’s Esophagus Progression Risk Beyond Biopsy Findings

Barrett’s esophagus is a precancerous condition associated with increased risk of esophageal adenocarcinoma. Routine endoscopic biopsy findings guide surveillance and therapy, but histopathology may not... Read more

Technology

view channel
Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detectio...
New Automation Workflow Streamlines NGS Library Preparation for High-Volume Labs
ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Hospital Partnership Advances Clinical Validation of Portable Diagnostic Technol...
Agilent's Acquisition of Proscia to Advance AI-Enabled Digital Pathology Workflo...
Diazyme Expands Chemistry Testing Portfolio With Alfa Wassermann Acquisition
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
Industry
BioResearch
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
ADLM WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica

 

ADLM Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE